Report - AGOF dmexco 2011 Sonderbericht Gesundheit FINAL2 · 6.1 Case Study NOVARTIS / Voltaren 6.2 Case Study Peter Kölln AG 6.3 Case Study Pharmakonzern / Medikament gegen Allergien 7.

Please pass captcha verification before submit form